• Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
N/A

N/A

-
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR202020212022
Revenues000000000000
EBITDA000000000000
Profit000000000000
EV000000000000
EV / revenue00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x
R&D budget000000000000

Source: Company filings or news article

Notes (0)
More about trackle
Made with AI
Edit

trackle GmbH is a German medical technology company operating in the FemTech sector, established to provide women with a hormone-free method for cycle tracking and fertility management. The company was founded in Bonn in 2015 by the husband-and-wife team, Katrin Reuter and Maxim Loick. The inspiration for trackle came from their personal experience with the symptothermal method for family planning; they sought a more convenient and reliable alternative to manual daily temperature measurements. Reuter, who now serves as CEO, has a background in political science and previously worked as an IT project manager, an experience that informed the development of trackle's user-focused technology.

The core of trackle's business is a sensor system designed to simplify fertility awareness. The product consists of a small, tampon-sized vaginal sensor that measures the user's core body temperature overnight, eliminating the inaccuracies and inconvenience associated with morning temperature readings. In the morning, the user syncs the sensor with a companion mobile app, which also allows for the input of other fertility indicators, such as cervical mucus consistency. The system's algorithms then analyze this data to determine whether the day is fertile or infertile, catering both to women seeking to avoid pregnancy without hormones and those trying to conceive. The business model is direct-to-consumer (B2C) through retail and e-commerce channels.

As a certified manufacturer of a Class IIb medical device, trackle adheres to the stringent requirements of the Medical Devices Directive 93/42/EEC and holds an EN ISO 13485:2016 certification, underscoring its commitment to product safety and quality. This certification distinguishes it in the market and provides a level of security comparable to hormonal contraceptives. The company has received seed funding from investors including Digital Hub, Capacura, and VentureOut. Since its inception, trackle has grown to serve over 50,000 customers and now employs a team of around 30 people, expanding its presence into several other European countries.

Keywords: fertility tracker, FemTech, medical device, cycle tracking, hormone-free contraception, natural family planning, symptothermal method, core body temperature, ovulation tracking, women's health, wearable sensor, reproductive health, conception aid, fertility awareness, MedTech, Katrin Reuter, B2C e-commerce, ISO 13485, cycle computer, fertility window

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo